2 research outputs found
Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design
No full textThe discovery of a highly potent
and selective small molecule inhibitor <b>9</b> for in vitro
target validation of MNK1/2 kinases is described.
The aminopyrazine benzimidazole series was derived from an HTS hit
and optimized by utilization of a docking model, conformation analysis,
and binding pocket comparison against antitargets
Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design
No full textThe discovery of a highly potent
and selective small molecule inhibitor <b>9</b> for in vitro
target validation of MNK1/2 kinases is described.
The aminopyrazine benzimidazole series was derived from an HTS hit
and optimized by utilization of a docking model, conformation analysis,
and binding pocket comparison against antitargets
